Filed in archive
Developments
, Research
, Treatment
by Gloria Gamat on April 9, 2008
Based in San Diego, California (USA), Novocell Inc. has found a potential in their human embryonic stem cells for diabetes cure.
As reported by Novocell's team of researchers in the journal Nature Biotechnology:
Human stem cells transformed into nearly normal insulin-producing cells when implanted into mice, possibly offering a way to treat diabetes long-term.
Yes, human embryonic stem cells are indeed the most powerful of stem cells, BUT the most controversial.
So, let's wait and see how this goes.
As reported by Novocell's team of researchers in the journal Nature Biotechnology:
Human stem cells transformed into nearly normal insulin-producing cells when implanted into mice, possibly offering a way to treat diabetes long-term.
The researchers used human embryonic stem cells - the most powerful but the most controversial source of stem cells.
"Our data provide the first compelling evidence that human embryonic stem cells can serve as a renewable source of functional insulin-producing cells for diabetes cell replacement therapies," said Emmanuel Baetge, chief scientific officer of Novocell.
Yes, human embryonic stem cells are indeed the most powerful of stem cells, BUT the most controversial.
So, let's wait and see how this goes.
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/119732
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for Novocell's Human Stem Cells, Treat Diabetes in Mice:
|
Rating: 9.00 out of 1 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
